Industry News

• UNMC enrollment reaches record high for sixth consecutive year  For the sixth straight year, student enrollment at the University of Nebraska Medical Center set a record high with 3,486 students enrolled for the 2010-11 school year -- an increase of 7.7 percent over last year's previous record total of 3,237.
  University of Nebraska Medical Center September 03, 2010  
• European Commission issues positive decision for approval of Seroquel XR  AstraZeneca announced the European Commission issued a positive decision for the approval of once-daily SEROQUEL XR Extended Release Tablets as an add-on treatment of major depressive episodes in patients with Major Depressive Disorder who had sub-optimal response to antidepressant monotherapy.
  AstraZeneca September 02, 2010  
• New England Journal of Medicine reports Xpert MTB/RIF a faster Tuberculosis test  New England Journal of Medicine reports Xpert MTB/RIF a faster, more Cepheid announced that its Xpert(R) MTB/RIF test was the subject of a study published in the latest edition of the New England Journal of Medicine (NEJM), "Rapid Molecular Detection of Tuberculosis and Rifampin Resistance."
  Cepheid September 02, 2010  
• Halozyme begins phase 2 clinical trial with insulin analogs Lispro and Aspart with rHuPH20  Halozyme Therapeutics announced the initiation of two Phase 2 Ultrafast Insulin treatment studies that utilize its rHuPH20 hyaluronidase enzyme in combination with the two leading commercially available mealtime analogs: insulin aspart, NovoLog, and insulin lispro, the active ingredient in Humalog.
  Halozyme Therapeutics, Inc. September 02, 2010  
• XOMA regains NASDAQ compliance  XOMA announced that NASDAQ has notified the Company that it regained compliance with the minimum $1.00 per share bid price requirement for continued listing. Accordingly, the Company will continue to be listed on The NASDAQ Global Market.
  XOMA Ltd. September 02, 2010  
• XOMA regains NASDAQ compliance  XOMA announced that NASDAQ has notified the Company that it regained compliance with the minimum $1.00 per share bid price requirement for continued listing. Accordingly, the Company will continue to be listed on The NASDAQ Global Market.
  XOMA Ltd. September 02, 2010  
• Bionovo receives NIH grant to develop drugs for the treatment of female-specific obesity  Bionovo announced that the NIH, National Center for Complementary and Alternative Medicine Small Business Technology Transfer Program, has approved and funded a grant to be shared by Bionovo and Dr. Dale Leitman from the University of California at Berkeley.
  Bionovo, Inc. September 02, 2010  
• BSD Medical reports receipt of safety certification for MicroThermX Microwave System  BSD Medicalday reported that it has received certification that the MicroThermX Microwave Ablation System (MTX-180) meets all requirements for safety and performance needed for compliance with the IEC 60601-1, safety standard, "Medical Electrical Equipment Part 1: General Requirements for Safety".
  BSD Medical Corporation September 01, 2010  
• Allergan resolves investigation of past sales and marketing practices related to BOTOX(R)  Allergan announced a resolution with the U.S. Department of Justice regarding Allergan's past U.S. sales and marketing practices relating to therapeutic uses of BOTOX. Allergan pled guilty to a single misdemeanor "misbranding" charge covering the period 2000 through 2005 and will pay $375 million.
  Allergan, Inc. September 01, 2010  
• Nebraska tracking system assesses developmental needs for premature infants  Risks for premature babies can include heart and lung complications, cerebral palsy, blindness and deafness. Because of a unique Nebraska program called Tracking Infants Progress Statewide (TIPS), infant needs for development services are identified earlier, at just 16 months of age.
  University of Nebraska Medical Center September 01, 2010  

   (next 10 articles)